Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany
Publié dans: | Journal of Critical Care 66(2021)S. 187-188 |
---|---|
Auteurs principaux: | Köhler, Thomas (Auteur), Schwier, Elke (Auteur), Henzler, Dietrich (Auteur), Eickmeyer, Claas (Auteur) |
Format: | Article |
Langue: | English |
Publié: |
2021
|
Sujets: | |
Accès en ligne: | https://doi.org/10.1016/j.jcrc.2021.07.011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314144/ |
Documents similaires: | In:
Journal of Critical Care |
Documents similaires
-
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
par: Schultz, Philipp, et autres
Publié: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
par: Hawchar, Fatime, et autres
Publié: (2022) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
par: Köhler, Thomas, et autres
Publié: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
par: Köhler, Thomas, et autres
Publié: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
par: Unterberg, Matthias, et autres
Publié: (2022)